ResMed shares have been caught up in the recent market volatility. Has this created a buying window for ResMed shares?

Shares of ResMed Inc. RMD advanced 5.82% to $216.44 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to 5,456.90 and ...

Let's see what the broker is saying about these healthcare stocks. The post Trump 2.0: Macquarie's take on the winners and ...

King Charles and Queen Camilla’s lasting marriage may owe credit to a “sleep divorce.” According to royal insiders, the ...

In a report released today, David Bailey from Morgan Stanley maintained a Buy rating on CSL (CMXHF – Research Report), with a price target of ...

Fisher & Paykel is well-positioned to benefit from long-term growth prospects in hospital and home respiratory care. Increasing adoption of nasal high flow, or NHF, therapy in the hospital division is ...

Drawing on analysis by UBS, we’ve identified the Aussie stocks that can weather a weak dollar and are primed for a bounce.

Mineral Resources, BHP, Magellan, GQG, Macquarie and CSL are hitting 52-week lows. Are they falling knives or hidden gems?

Global pharma and MedTech stocks rebound as U.S. President Donald Trump issues a 90-day pause on reciprocal tariffs for all ...